First-in-Human Study of ISH0613: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics

Clinical trial NCT07516639 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07516639
Sponsor: SUNHO（China）BioPharmaceutical CO., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects (HS)SLE (Systemic Lupus)

Start date: 2026-04-01
Primary completion: 2026-12-31
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.